New research has demonstrated the antidepressant and anti-stress effects of KNT-127, a potent delta opioid receptor (DOP) agonist, in a mouse model. The study showed KNT-127 reducing inflammation and newborn neuronal death in the hippocampus, potentially offering a more effective, faster-acting treatment for depression with fewer side effects than conventional antidepressants.
Researchers have developed a potential depression treatment that demonstrates both stress-relieving and anti-depressant effects with minimal side effects.
Millions of individuals globally grapple with depression…
Continue Reading
News Source: scitechdaily.com